Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
In8Bio Inc
(NQ:
INAB
)
0.2710
+0.0409 (+17.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,457,211
Open
0.2300
Bid (Size)
0.2700 (110)
Ask (Size)
0.2740 (38)
Prev. Close
0.2301
Today's Range
0.2300 - 0.2730
52wk Range
0.2170 - 2.480
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 08, 2024
Via
Benzinga
Performance
YTD
-79.47%
-79.47%
1 Month
-17.88%
-17.88%
3 Month
-67.35%
-67.35%
6 Month
-73.69%
-73.69%
1 Year
-71.77%
-71.77%
More News
Read More
INAB Stock Earnings: IN8bio Misses EPS for Q2 2024
August 09, 2024
Via
InvestorPlace
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
INAB Stock Earnings: IN8bio Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 07, 2024
Via
Benzinga
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 09, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
April 30, 2024
From
IN8bio, Inc
Via
GlobeNewswire
INAB Stock Earnings: IN8bio Misses EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
April 24, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
April 16, 2024
From
IN8bio, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
Kill Leukemia Cells While Preserving Healthy Tissues: Nano-Cap Cancer Focused Firm IN8bio's Preclinical Candidate Shows Potential
April 10, 2024
Via
Benzinga
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
April 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 10, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 10, 2024
Via
InvestorPlace
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
April 09, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
March 14, 2024
From
IN8bio, Inc
Via
GlobeNewswire
IN8bio to Present at Upcoming Investor Conferences
February 26, 2024
From
IN8bio, Inc.
Via
Business Wire
IN8bio’s Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
January 23, 2024
Via
News Direct
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 15, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.